
5.11 Delayed Data As of Sep 26 | ![]() Today’s Change | 1.70 Today|||52-Week Range 10.90 | +180.77% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $14.0M |
Eloxx Pharmaceuticals, Inc. 480 Arsenal Way Watertown Massachusetts 02451 |
Sumit Aggarwal | President, Chief Executive Officer & Director |
Daniel E. Geffken | Chief Financial & Accounting Officer |
Vijay Modur | Head-Research & Development |
Ali Hariri | Chief Medical Officer |
Barbara Ryan | Investor Relations Contact |